BETAHISTINE: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.
Brand(s)
Last updated
Summary
Product
BETAHISTINE
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| BETAHISTINE | BETAHISTINE 16MG | DIN 02466449 | Tablet | BETAHISTINE HYDROCHLORIDE 16mg | 100039203 100047036 100053524 100059890 100062445 |
| BETAHISTINE | BETAHISTINE 24MG | DIN 02466457 | Tablet | BETAHISTINE HYDROCHLORIDE 24mg | 100039462 100049894 |
Issue
Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Pharmacy
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Sanis Health Inc.
1 Presidents Choice Circle
Brampton, Ontario
L6Y 5S5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-76647
Get notified
Receive notifications for new and updated recalls and alerts by category.